Extracellular Matrix-derived Nanoparticles For Imaging And Immunomodulation

1y ago
4 Views
1 Downloads
2.46 MB
62 Pages
Last View : 1m ago
Last Download : 3m ago
Upload by : Amalia Wilborn
Transcription

EXTRACELLULAR MATRIX-DERIVEDNANOPARTICLES FOR IMAGING ANDIMMUNOMODULATIONBY:JOHN KRILLA THESIS SUBMITTED TO JOHNS HOPKINS UNIVERSITY IN CONFORMITY WITHTHE REQUIREMENTS FOR THE DEGREE OF MASTER IN SCIENCE ANDENGINEERINGBALTIMORE, MARYLANDMAY, 2016 2016 JOHN KRILLALL RIGHTS RESERVED

ABSTRACTThe extracellular matrix (ECM) is a complex component of tissue that includes collagens,glycoproteins, proteoglycans, and elastic fibers. These proteins serve both as a structuralfoundation upon which cells organize and communicate, and to inherently direct manyphysiological phenomena within cells, such as migration, proliferation, and differentiation. Dueto these unique properties of ECM, laboratory generated matrix derived from the decellularizationof native tissue, has become a preferred scaffolding material for use in tissue engineering andregenerative medicine. ECM particulate forms have been of increasing interest, as they provideseveral advantages over macro-scale patches. Particles enable minimally invasive deliveryalternatives, including injections. In addition, by reducing ECM particle size to the nanoscale,ECM can be directly taken up by cells, such as macrophages, through phagocytosis or otherengulfment methods. This internalization of ECM may lead to enhanced potency of directing cellbehavior or differentiation versus simple material contact. This is highly relevant in thedevelopment of immune therapies that aim to modulate the host immune response for morepositive outcomes in cancer treatment, implant integration, and vaccines.This thesis has two major parts. First, the methodology and characterization ofsuccessfully produced ECM nanoparticles derived from several porcine tissue sources areprovided. This encompasses the tissue decellularization process and nanoparticle generationprocedure. The second part focuses on modification of ECM nanoparticles with a variety ofmolecules, including fluorescent dyes, polyethylene glycol and functional peptides to alter theirproperties. Preliminary data regarding the ability of non-modified ECM nanoparticles to influencemacrophage polarization in vitro is offered, with changes in cytokine expression suggestingimmunomodulatory effects. Overall, ECM nanoparticles are a promising biomaterial for medicalimaging, cancer research and immunology, and thus deserve further exploration.Thesis Readers: Dr. Jennifer H. Elisseeff, Dr. Kevin Yarema, and Dr. Hai-Quan Maoii

SPECIAL THANKS TO:Dr. Matthew WolfTony WangChristopher AndersonAnd the rest of the Elisseeff Lab for their assistance and guidance throughout this entire project,as well as members from the Green and Yarema Labs who facilitated many of these studies.iii

TABLE OF CONTENTSList of Tables . vList of Figures . vi1. Introduction1.1 Overview of ECM . 11.2 ECM as a Biomaterial in Tissue Repair. 41.3 ECM in Immunology . 81.4 ECM Particulates: Unlocking New Applications . 122. Decellularization Process2.1 Tissue Decellularization Methodology . 142.2 ECM Characterization . 153. ECM Nanoparticle Preparation3.1 Cryomilling to Generate Micron-Scale Powder . 173.2 Processing of ECM Powder Into Nanoparticles . 203.3 ECM Nanoparticle Characterization . 223.4 ECM Nanoparticle Cytotoxicity Studies . 254. ECM Nanoparticle Modification and Functionalization4.1 Fluorescent Marker Conjugation . 294.2 PEGylation. 395. Effect of ECM Nanoparticles on Macrophage Polarization5.1 Intrinsic ability of ECM Nanoparticles to Influence Macrophage Polarization . 445.2 Functionalization of ECM Nanoparticles for Immune Therapy: Future Works . 476. Conclusion . 50References . 51Curriculum Vitae . 55iv

LIST OF TABLESTable 1: List of common ECM components, their functions and where they can be found withinthe body . 3Table 2: Examples of commercially available scaffolds composed of ECM . 8Table 3: Abbreviated list of associated factors for M1 and M2 macrophage phenotypes . 11Table 4: Overview of PAA/Triton decellularization procedure . 14Table 5: Overview of SDS Decell Procedure . 15Table 6: Settings used for SPEX sampleprep 6870 freezer/mill . 18Table 7: Emulsiflex operating pressures for ECM nanoparticle generation . 21Table 8: List of NHS dyes successfully conjugated to ECM nanoparticles. 38v

LIST OF FIGURESFigure 1: H&E comparison of decellularized ECM batches with native tissue counterparts . 16Figure 2: Masson’s trichrome comparison of decellularized ECM batches with native tissuecounterparts . 17Figure 3: Size comparisons of multiple cryomilled ECM batches . 18Figure 4: SEM images highlighting morphology differences between ECM powders . 20Figure 5: Representative size profile for ECM nanoparticle batches . 23Figure 6: Cumulative Z-averages and PDIs of ECM nanoparticle batches . 23Figure 7: Effects of filtering on ECM nanoparticle batches . 24Figure 8: Cell counts for polystyrene beads added to hASCs . 26Figure 9: Cell counts for lower concentrations of polystyrene beads added to hASCs . 27Figure 10: hASC viability images under addition of various nanoparticles . 28Figure 11: Cell counts for hASC viability images under addition of various nanoparticles . 29Figure 12: NHS-ester chemistry overview. 30Figure 13: Fluorescence microscope image of ECM particles . 31Figure 14: Centrifuge method to wash synthetic particles . 32Figure 15: Sizing data of ECM nanoparticle batch before and after centrifugation . 33Figure 16: Overview of centrifuge filter unit method to wash nanoparticles. . 33Figure 17: Size profile changes of FITC-ECM nanoparticles after centrifuge washing . 34Figure 18: Flow-through and fluorescence data of free dye and FITC-ECM nanoparticle batches. 34Figure 19: Comparison of FITC-NHS, fluorescein and glycine quenched ECM nanoparticlebatches . 35vi

Figure 20: Addition of FITC-tagged ECM nanoparticles to bone marrow-derived macrophages 37Figure 21: Signal-to-noise ratios of several dyes conjugated to ECM nanoparticles . 38Figure 22: Distribution of Licor-tagged ECM nanoparticles introduced by tail vein injection . 39Figure 23: Size profiles of ECM nanoparticle batches conjugated with NHS-PEG . 40Figure 24: Zeta potentials of ECM nanoparticle batches conjugated with NHS-PEG . . 41Figure 25: Illustration of QCM-D principles of operation . 42Figure 26: Real-time adsorption layer thickness of ECM nanoparticles onto QCM-D disks . 43Figure 27: Timeline of in vitro macrophage polarization study . 44Figure 28: Gene expression changes for several M1 and M2 associated factors produced by bonemarrow-derived macrophage after exposure to cardiac ECM nanoparticles . 46Figure 29: Simplified T cell activation pathway demonstrating antigen presentation to triggerstimulation of immature T cells into cytotoxic CD8 T cells. . 48vii

1. INTRODUCTION1.1 OVERVIEW OF ECMThe tissue microenvironment is composed of two major components: cells and asurrounding extracellular matrix (ECM). This ECM consists of a complex combination ofproteins and polysaccharides secreted by resident cells that influence and direct manyphysiological phenomenon. These molecules include collagens, elastins and proteoglycans, theratios of which differ depending on the tissue source. By considering the components of ECMand analyzing their functions within the body, we can appreciate the myriad of applications thatECM-derived materials have in tissue engineering, wound healing and immunology.The ECM was first credited for providing a structural foundation on which cells canorganize and communicate. Two of the major structural contributors to ECM are collagens andelastic fibers.[1] Collagens are comprised of three polypeptide -chains that wrap around eachother to form highly stiff triple-helices, called tropocollagens. Based on the -chain peptidecomposition, tropocollagen molecules assemble together to form a wide variety of largerarchitectures, including fibrillar structures, beaded fibrillar strings and hexagonal networks. Thissupramolecular structure dictates the overall properties of the final collagen product.[2][3] Forexample, fibrillar type I collagen found in tendons grants outstanding tensile strength and slightelastic properties that enables contraction and stretching without tearing.[4] Over 28 classes ofcollagen have been identified and can be grouped into fibrillar, nonfibrillar, association,transmembrane and multiplexin classifications.[5][6] While each type of collagen has a uniquepurpose and location within the body, they generally serve to provide tensile strength to tissuesand form a framework on which cells can adhere to and organize on. Complementary tocollagens, elastic fibers are composed of a highly cross-linked network of flexible elastin proteinbundles. Found in the lungs, blood vessels, dermis and many other tissues, elastin networksprovide elastic properties to tissues, enabling their recoil to original dimensions upon the removal1

of a deforming force. Elastic fibers are heavily associated with the microfibrillar proteins fibrillinand fibulin, both of which mediate elastic fiber formation and also confer inherent mechanicalstability in non-elastic tissues.[7][8]Collagens, elastic networks and various other proteins are highly incorporated in aviscous milieu comprising mainly of proteoglycans.[9] These structures consist of a core proteinwith many covalently attached glycosaminoglycan (GAG) chains branching off. Thesepolysacharride chains tend to be extremely hydrophilic, causing them to spread out and occupylarge volumes in aqueous environments. Because of the sulfate and carboxyl groups located onthe sugars of GAGs, these chains are typically highly negative. This attracts osmotically activecations such as Na , which absorb water and leads to the formation of gels that providecompressive resistance to surrounding tissues.[9]There are many other notable molecules that contribute to the ECM’s composition,including laminins and fibronectin, which are listed in Table 1. It is important to note that all ofthese components play a far more complex and dynamic role in the cellular environment thansimply providing a structural foundation. Cells secrete many signaling molecules into theextracellular space that interact with the matrix, including growth factors, cytokines andproteases. Collagen networks help sequester these molecules until they are needed.[6]Proteoglycans often interact with these secreted factors, mediating a variety of cell behaviors. Forexample, heparan sulfate chains in GAGs bind to and regulate fibroblast growth factors (FGFs),which have implications in angiogenesis, development, proliferation and wound healing.[9][11]Certain members of the transforming growth factor- (TGF- ) family have demonstrated bindingto decorin, a proteoglycan core protein found in bone matrix, to enhance its bioactivity.[12] TGF- is secreted by white blood cell lineages and is highly important in immunology. Proteoglycansalso bind to proteases and protease inhibitors that control the production and degradation of theECM material, including matrix metalloproteases and serine proteases. These proteases helpdetach cells from the matrix and enable cell migration by creating pathways through which they2

can travel.[9] Hyaluronan, a GAG not bound to a core protein, serves as an important matrixcomponent during embryonic development and in adult tissues, forms complexes withproteoglycans, and also generates empty spaces in which cells can migrate during woundhealing.[9] The elastic fiber components fibrillin and fibulin also mediate all sorts of cellularactivity, including normal lung and kidney development, matrix deposition, and activation ofTGF- and bone morphogenetic protein-7 in mice.[8]Table 1: List of common ECM components, their functions and where they can be found within the body.[5]FunctionExample LocationsFibrillar CollagensStructural, cell adhesion andBone, dermis, heart (I); cartilage (II);I, II, III, V, XIproliferation, mediates proteoglycangranulation tissue (III); basement membraneinteractions(V); articular cartilage, ear (XI)Nonfibrillar collagensStructural, angiogenesis,Kidney (IV); sclera and vasculature (VIII);IV, VIII, Xcompartmentalizes ECMhypertrophic cartilage (X)componentsAssociation collagensStructural, interaction with otherLiver (VI); basement membrane (VII);VI, VII, IX, XII, XIV, XIXECM components,cartilage (IX), skin (XII); blood vessels(XIV); muscle cells (XIX)Transmembrane collagensStructural, interacts with ECMSkin (XIII); cutaneous basement membraneXIII, XVIIcomponents, cell-matrix adhesion(XVII)MultiplexinsOrganizes ECM, inhibitsBasement membraneXV, XVIIIangiogenesis and tumor growthElastinStructural, provides elasticityLungs, blood vessels, dermisFibrillinsStructural, tissue homeostasisMicrofibrilsFibulinsStructural, interacts with ECMBasement membrane, blood vessels1, 2, 3, 4, 5, 6, 7components, modulates platelet1, 2adhesion, angiogenesis, formationof elastic fibersHyaluronanHyalectansAngiogenesis, cell motility, woundMost tissues; notably skin, cartilage, vitreoushealing, cell adhesionhumour, jointsStructural, interacts with ECMArticular cartilage (aggrecan), braincomponents, cell adhesion and(brevican, neurocan), blood vessels (versican)migrationFibronectinCellular adhesion, ECM assembly,Most tissuestissue injury and inflammation,angiogenesisLamininsCell adhesion, migration anddifferentiation3Basement membrane

These are just several examples in which extracellular matrix components regulatecellular activity, though there are many others. However, these brief examples illustrate theeffectiveness of ECM components to influence cell organization, proliferation, differentiation andmigration. The effect goes both ways. While the ECM provides physical and chemical cues thatdirect cell behavior, the cells also produce cytokines that remodel the ECM. This dynamicreciprocity is important in homeostasis and tissue repair, as will be discussed in followingsections.[29-31] With the ECM playing such a critical role in cell behavior, it makes sense toconsider this material in biomedical applications.1.2 ECM AS A BIOMATERIAL IN TISSUE REPAIRWith the extracellular matrix directing so many physiological phenomena, there has beenan increasing interest in isolating ECM material for use as a biomaterial in tissue repair. Upon adestructive stimulus, the wound repair process is triggered. Regardless of the type or location ofinjury, this process is highly directed by chemical signals, including numerous cytokines andgrowth factors, and generally involves three major overlapping steps: inflammation, cellproliferation and remodeling.[13][14] Immediately after injury, circulating platelets adhere toexposed collagen in the tissue. These platelets produce clotting factors that trigger the formationof a provisional fibrin matrix, as well as platelet-derived growth factor (PDGF) and transforminggrowth factor-beta (TGF- ) that signal the chemotaxis of neutrophils, macrophages, smoothmuscle cells and fibroblasts to the damaged region. TGF- also plays a role in stimulatingmacrophages to produce pro-inflammatory cytokines, including tumor-necrosis factor-alpha(TNF- ) and interleukin-1 (IL-1). Recruited neutrophils, as well as macrophages differentiatedfrom monocytes, actively remove dead tissue and foreign material through phagocytosis. Upontransition to the proliferation phase, the fibrin matrix is replaced with granulation tissue, andangiogenesis facilitated by vascular endothelial growth factor A (VEGFA) and fibroblast growthfactor 2 (bFGF) occurs. Macrophages can release soluble factors that trigger the differentiation of4

some fibroblasts into myofibroblasts, which work towards closing the wound and depositing newECM. In the last stage, the newly deposited matrix is remodeled by matrix metalloproteinases,which typically involves the conversion of type-III collagen to type-I, and the tissue achieveshomeostasis.This describes the typical wound-healing cascade in many tissues. However, injuriesinvolving high volumetric damage or non-regenerative tissues (i.e. cardiac) may result inalternative responses, including excessive or deficient healing.[14] Excessive healing, commonlyknown as fibrosis, leads to the deposition of too much matrix material that interferes with propertissue re-growth, resulting in an overall loss in tissue functionality. The build-up of this nonfunctional tissue is thought to lead to many diseases, including congestive heart failure, cirrhosisof the liver, transmission blockage following nerve injury and hypertrophic scarring. Deficienthealing can occur when infiltrating neutrophils degrade deposited matrix, for example throughcollagenase or elastase production, faster than it can accumulate. This is the main cause ofchronic ulcers that affect debilitated and elderly patients.[14]Treatment for both overhealing and underhealing in patients focuses on theadministration of key growth factors or healthy cells to the defective area in attempts toregenerate functional tissue. However, single-agent therapies have seen limited success.[13]Delivery of individual growth factors shows little impact due to the redundant nature of thewound healing response and short half-life of the agent at the wound site. Cells delivered bythemselves are difficult to isolate and deliver while maintaining viability, and they lack thephysical and chemical cues that help them organize and proliferate. Thus, there has been a recenttrend in integrating both growth factors and cells into carefully engineered, three-dimensionalscaffolds that help promote proper incorporated cell organization and mimic specific biologicalsignals. Synthetic scaffolds derived from polymers have been used in this manner. For example,surgical implantation of porous poly(lactide-co-glycolide) scaffolds, loaded with autologousmesenchymal stem cells, demonstrated cartilage regeneration in damaged sheep joints.[15] Aligned5

electrospun poly-caprolactone fiber meshes displayed improved cell proliferation, migration andorientation in neural regeneration.[16] These polymer scaffolds, extending but not limited topolystyrene, poly-l-lactic acid, polyglycolic acid and poly (acrylonitrile-co-methacrylate), havealso shown some success in repairing bone defects, nerves, liver, skin and blood vessels.[15-17]However, while these synthetic scaffolds are highly customizable, easily reproduced, and haveshown positive tissue regeneration effects, their structures are often too simplistic to properlymimic the in vivo cell environment. The extracellular matrix is a highly complex threedimensional combination of proteins and secreted molecules, each with a unique structurespecifically suited to their function. A simple porous or mesh scaffold cannot replicate theintricate features of numerous matrix proteins, such as the triple helix of collagen or the carefullycross-linked network of elastin. As a result, synthetic scaffolds lack the true bioactivity of nativematrix that promotes proper cell differentiation and behavior. Synthetic scaffolds have also beenshown to trigger the host immune response, typically resulting in fibrous encapsulation of thescaffold.[18][19]ECM-derived scaffolds show much more promise in tissue repair, as they address manyof the problems found in their synthetic counterparts. As discussed previously, the in vivo cellularenvironment consists of a highly dynamic and complex extracellular matrix. The structure andcomposition of this matrix is optimized to promote cell adhesion, organization, proliferation,differentiation and migration through a combination of physical and chemical cues. Thus, byderiving the scaffold material from tissue ECM itself, we can inherit the native structural andfunctional molecules, as well as the exact three-dimensional environment, that providebioactivity.[13] ECM-derived scaffolds have been successfully produced and demonstrateimproved tissue regeneration in a wide variety of applications. A decellularized equine cartilagematrix scaffold was introduced in a horse knee containing a critically sized osteochondral defect.After 8 weeks, significant bone and cartilage regeneration was observed.[20] Implantation ofporcine urinary bladder matrix (UBM) facilitated constructive healing of the esophageal wall in a6

dog model, evidenced by growth of functional and innervated neotissue.[21] Porcine UBM wasalso capable of inducing reconstruction of the temporomandibular disk in vivo.[22] Tube-shapedECM scaffolds from porcine small intestine were implanted into patients suffering from highgrade dysplasia of the esophagus, showing rapid remodeling in the form of new epithelium andsubmucosal layer, and porcine small intestine submucosa (SIS) scaffolds implanted in a caninevolumetric muscle loss model showed formation of vascularized, functionally innervated skeletalmuscle.[21][23][24]Several FDA approved, commercially available ECM products are highlighted in Table2.[21][25] The production of these scaffolds requires careful washing of whole organs or tissuesections with a combination of detergents, acids, enzymatic solutions and other solvents. Thesesolutions work towards removing unwanted cellular material and solulizable proteins whilemaintaining the physical structure and key functional components of the organ or tissue. Ideally,decellularized ECM scaffolds retain all of the structural and functional proteins andpolysaccharides of native tissue, including collagens, GAGs, fibronectin and laminin ligands thatpromote cell adhesion and growth in a natural, organized three-dimensional space. These ECMcomponents are largely conserved across and within species and are relatively non-immunogenic.By removing the cellular content susceptible to immune recognition, decellularized ECMscaffolds can circumvent immunological complications witnessed by synthetic scaffolds.Tissues within the body vary greatly in morphology, cellular density, protein ratios andcomposition. The source of the ECM also dictates physical properties such as rigidity, porosityand topography. As a result, the optimal decellularization process may differ between each tissuetype. Most processes utilize a combination of the chemical decellularization agents mentionedabove, and physical disruption of the tissues to achieve acceptable decellularization. However, itis important to consider the impact of these treatments on the mechanical and physiologicalproperties of tissues. The physical architecture of proteoglycans, collagen fibers and otherproteins within tissues contributes greatly to its mechanical properties, and they also provide the7

matrix with functionality. Destruction of any component through too harsh a decellularizationprocess can lead to diminishing performance of the decellularized material. Badylak et al.provides a comprehensive summary of potential effects of many decellularization agents andprocesses.[26] Striking a balance between optimal cell removal and preservation of critical ECMcomponents is necessary for producing functional ECM materials.Table 2: Examples of commercially available scaffolds composed of ECM [21][25]ProductMaterialFormUseCompanyAlloDermHuman skinDry sheetAbdominal wall, breast, head andneck reconstruction, graftingLifeCellCollamendPorcine dermisDry sheetSoft tissue repairBardCuffPatchPorcine SISHydrated sheetSoft tissue reinforcementArthrotekMatristemPorcine UBMDry sheet;powderSoft tissue repairACellOasisPorcine SISDry sheetPartial and full-thickness burnsHealthpointPermacolPorcine skinHydrated sheetSoft connective tissue repairTissue d sheetSoft tissue repairSynovis SurgicalXenformFetal bovine skinDry sheetColon, rectal, urethral repairTEI BiosciencesZimmerCollagen PatchPorcine dermisDry sheetOrthopedic applicationsTissue ScienceLaboratoriesThis section served to highlight one of the prominent uses of extracellular matrix-derivedbiomaterials. Widely considered for tissue regeneration applications, ECM scaffolds showpromise in their ability to organize cells and produce functional tissue patches for wound repair.However, the extracellular matrix contributes to many more physiological phenomena within thebody, with host immunological response of particular interest.1.3 ECM IN IMMUNOLOGYHinted at earlier, immune cells play a critical role in every step of the wound healingprocess, with major players including neutrophils, eosinophils, basophils, dendritic cells,monocytes and macrophages, T cells and B cells. The recruitment of these cells and their8

behavior at the injury site are heavily influenced by local and systemic cascades of compleximmune events.[27] These events are often triggered and controlled by secreted cytokines or othersoluble mediators within the local tissue microenvironment, among which include numerousextracellular matrix components. For example, mindin is a secreted ECM protein that serves as anopsonin for macrophage phagocytosis of bacteria, and biglycan found commonly in bone,cartilage and tendon matrix can stimulate production of pro-inflammatory cytokines inmacrophages.[28][29]ECM remodeling plays a particularly important role in regulating the immune response.The breakdown of ECM components, either through interaction with adhered pathogens or byspecific proteases such as matrix metalloproteinases (MMPs), exposes cryptic binding sites thatfacilitate the activation of the innate immune response.[29] The detection of these sites by patternrecognition receptors on immune cells leads to the initiation of an inflammatory response thatenables infiltration of immune cells to the injured region. Among the major contributors are lowmolecular weight hyaluronan (LMWHA) fragments, which induce the release of proinflammatory cytokines TNF- and IL-1 by macrophages.[29] Fibronectin fragments expressingan extra domain A have demonstrated activation of receptors that induce responses similar tothose triggered by bacteria.[30] In addition to initiating the inflammatory response, ECM fragmentsalso act as chemoattractants that further promote cell infiltration.[31] For example, specificcleavage of collagen I by MMPs generates fragments that contribute to neutrophil recruitment inthe early stages of inflammation. Elastin fragments demonstrate similar chemotactic propertiesfor monocytes. The release of cytokines by infiltrating cells also helps to tailor the production ofMMPs and subsequent generation of ECM fragments, re-illustr

ii ABSTRACT The extracellular matrix (ECM) is a complex component of tissue that includes collagens, glycoproteins, proteoglycans, and elastic fibers.

Related Documents:

CONTENTS CONTENTS Notation and Nomenclature A Matrix A ij Matrix indexed for some purpose A i Matrix indexed for some purpose Aij Matrix indexed for some purpose An Matrix indexed for some purpose or The n.th power of a square matrix A 1 The inverse matrix of the matrix A A The pseudo inverse matrix of the matrix A (see Sec. 3.6) A1 2 The square root of a matrix (if unique), not elementwise

A Matrix A ij Matrix indexed for some purpose A i Matrix indexed for some purpose Aij Matrix indexed for some purpose An Matrix indexed for some purpose or The n.th power of a square matrix A 1 The inverse matrix of the matrix A A The pseudo inverse matrix of the matrix A (see Sec. 3.6) A1/2 The square root of a matrix (if unique), not .

CONTENTS CONTENTS Notation and Nomenclature A Matrix Aij Matrix indexed for some purpose Ai Matrix indexed for some purpose Aij Matrix indexed for some purpose An Matrix indexed for some purpose or The n.th power of a square matrix A 1 The inverse matrix of the matrix A A The pseudo inverse matrix of the matrix A (see Sec. 3.6) A1/2 The square root of a matrix (if unique), not elementwise

Bruksanvisning för bilstereo . Bruksanvisning for bilstereo . Instrukcja obsługi samochodowego odtwarzacza stereo . Operating Instructions for Car Stereo . 610-104 . SV . Bruksanvisning i original

CONTENTS CONTENTS Notation and Nomenclature A Matrix A ij Matrix indexed for some purpose A i Matrix indexed for some purpose Aij Matrix indexed for some purpose An Matrix indexed for some purpose or The n.th power of a square matrix A 1 The inverse matrix of the matrix A A The pseudo inverse matrix of the matrix A (see Sec. 3.6) A1 2 The sq

Alginate nanoparticles were the most stable in the salivary environment, while chitosan nanoparticles were the most cytocompatible. Alginate nanoparticles and pectin nanoparticles revealed possible cytotoxicity due to the presence of zinc. This knowledge is important in the early design of polymer-based nanoparticles for oral

10 tips och tricks för att lyckas med ert sap-projekt 20 SAPSANYTT 2/2015 De flesta projektledare känner säkert till Cobb’s paradox. Martin Cobb verkade som CIO för sekretariatet för Treasury Board of Canada 1995 då han ställde frågan

2 For referenced ASTM standards, visit the ASTM website, www.astm.org, or contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM Standards volume information, refer to the standard’s Document Summary page on the ASTM website. 1